Eosinophilic cystitis is a rare, easily treatable, and important differential of bladder mass in children, which may present with an atypical obstructive uropathy.
A practical guide to the diagnosis, management, and treatment of complications associated with CAR T cell-therapy, ranging from cytokine release syndrome to neurotoxicity.
A liberal transfusion strategy does not reduce the risk for an unfavorable neurological outcome after traumatic brain injury compared with a restrictive strategy.
What are the possible causes of thrombocytopenia in patients with sepsis? Learn more in this review and discover a novel practical approach to diagnosis and treatment.
Our tailored content service will keep you up to date…
Receive newsletters curated for the busy specialist by our expert editorial team
How do nutrition, supplements and antibiotics impact patient outcomes?
Recent research suggests that the gut microbiome could be an important modulator of response to CAR T-cell therapy in patients with hematologic cancers.
Prof. Marion Subklewe takes us through the latest evidence, highlighting the impact of antibiotics, nutrition, and dietary supplements, and discusses how to devise interventions to improve patient outcomes.
Eosinophilic cystitis is a rare, easily treatable, and important differential of bladder mass in children, which may present with an atypical obstructive uropathy.
Nephrotic syndrome is usually caused by primary renal disorders, but you should consider metabolic diseases in atypical cases. This 7-month-old presented with nephrotic syndrome, malignant hypertension, and hemolytic anemia.
A 17-year-old presented with non-necrotizing scleritis, anterior uveitis, vitritis, yellowish chorioretinal lesions, papillitis, and vasculitis. Would you consider Hodgkin lymphoma in the differential diagnosis?
We present three cases of eosinophilic granulomatosis with polyangiitis (EGPA) where patients experienced relapse of eosinophilic sinusitis without peripheral eosinophilia while on remission maintenance therapy with mepolizumab (MPZ), an …
Paroxysmal nocturnal haemoglobinuria (PNH) is a rare, complement-associated, haematological disorder. The level of knowledge about the disease and its management varies around the world. This narrative review provides an overview of available …
The interplay between the immune system, coagulation, and endothelium is critical in regulating the host response to infection. However, in sepsis and other critical illnesses, a dysregulated immune response can lead to excessive alterations in …
The latest evaluation by GLOBOCAN 2020 indicates that approximately 133,354 new cases and 80,008 new deaths of nasopharyngeal carcinoma (NPC) have been recorded, making up 0.7% and 0.8% of total cancer, respectively. More men than women were …
A series of patient cases underpin this interactive webinar that aims to provide practical guidance on a multidisciplinary approach to managing patients with cutaneous T-cell lymphoma.
An independent symposium at the 10th COMy World Congress focusing on BCMA-targeting strategies for the treatment of multiple myeloma. Gain insights into the latest clinical data and the implications for clinical practice.
In this live webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.
Please note, this webinar is not intended for healthcare professionals based in the US and UK.
Kidney involvement is common in childhood-onset systemic lupus erythematosus (cSLE), occurring in around 50–80% of patients [ 1 , 2 ]. Around 4% of cSLE develop advanced chronic kidney disease (CKD) [ 2 , 3 ]. Up to 15% of patients with …
Paroxysmal nocturnal haemoglobinuria (PNH) is a rare, complement-associated, haematological disorder. The level of knowledge about the disease and its management varies around the world. This narrative review provides an overview of available …
Extensive-stage small cell lung cancer (ES-SCLC) represents a therapeutic challenge due to the aggressive nature of tumor growth, early metastatic spread, and the lack of targetable mutations [ 1 ]. Nonetheless, platinum-based cytotoxic …
Patients receiving myelotoxic treatment for haematological malignancies are at high risk for bloodstream infections (BSI) and sepsis, which brings about a significant risk of intensive care admission and treatment-related mortality [ 1 ]. Many …
